434 related articles for article (PubMed ID: 24292789)
1. Iontophoretic transdermal delivery of glycyrrhizin: effects of pH, drug concentration, co-ions, current intensity, and chemical enhancers.
Yamamoto R; Takasuga S; Kominami K; Sutoh C; Kinoshita M; Kanamura K; Takayama K
Chem Pharm Bull (Tokyo); 2013; 61(12):1275-81. PubMed ID: 24292789
[TBL] [Abstract][Full Text] [Related]
2. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
[TBL] [Abstract][Full Text] [Related]
3. Transdermal delivery of cytochrome C--A 12.4 kDa protein--across intact skin by constant-current iontophoresis.
Cázares-Delgadillo J; Naik A; Ganem-Rondero A; Quintanar-Guerrero D; Kalia YN
Pharm Res; 2007 Jul; 24(7):1360-8. PubMed ID: 17457661
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo transdermal iontophoretic delivery of naloxone, an opioid antagonist.
Yamamoto R; Takasuga S; Yoshida Y; Mafune S; Kominami K; Sutoh C; Kato Y; Yamauchi M; Ito M; Kanamura K; Kinoshita M
Int J Pharm; 2012 Jan; 422(1-2):132-8. PubMed ID: 22108639
[TBL] [Abstract][Full Text] [Related]
5. Transdermal iontophoresis of dexamethasone sodium phosphate in vitro and in vivo: effect of experimental parameters and skin type on drug stability and transport kinetics.
Cázares-Delgadillo J; Balaguer-Fernández C; Calatayud-Pascual A; Ganem-Rondero A; Quintanar-Guerrero D; López-Castellano AC; Merino V; Kalia YN
Eur J Pharm Biopharm; 2010 Jun; 75(2):173-8. PubMed ID: 20332024
[TBL] [Abstract][Full Text] [Related]
6. Delivery of a classical antihypertensive agent through the skin by chemical enhancers and iontophoresis.
Nair A; Reddy C; Jacob S
Skin Res Technol; 2009 May; 15(2):187-94. PubMed ID: 19622129
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins.
Dubey S; Kalia YN
J Control Release; 2010 Aug; 145(3):203-9. PubMed ID: 20423719
[TBL] [Abstract][Full Text] [Related]
8. Effect of permeation enhancers on the iontophoretic transport of metoprolol tartrate and the drug retention in skin.
Nair A; Vyas H; Shah J; Kumar A
Drug Deliv; 2011 Jan; 18(1):19-25. PubMed ID: 20726811
[TBL] [Abstract][Full Text] [Related]
9. In-vitro and in-vivo transdermal iontophoretic delivery of tramadol, a centrally acting analgesic.
Takasuga S; Yamamoto R; Mafune S; Sutoh C; Kominami K; Yoshida Y; Ito M; Kinoshita M
J Pharm Pharmacol; 2011 Nov; 63(11):1437-45. PubMed ID: 21988424
[TBL] [Abstract][Full Text] [Related]
10. Transdermal iontophoresis of hydromorphone across hairless rat skin in vitro.
Kumar MG; Lin S
Pharm Dev Technol; 2009; 14(1):106-15. PubMed ID: 18825546
[TBL] [Abstract][Full Text] [Related]
11. A combination of nonionic surfactants and iontophoresis to enhance the transdermal drug delivery of ondansetron HCl and diltiazem HCl.
Silva SM; Hu L; Sousa JJ; Pais AA; Michniak-Kohn BB
Eur J Pharm Biopharm; 2012 Apr; 80(3):663-73. PubMed ID: 22137964
[TBL] [Abstract][Full Text] [Related]
12. Microneedle assisted iontophoretic transdermal delivery of prochlorperazine edisylate.
Kolli CS; Xiao J; Parsons DL; Babu RJ
Drug Dev Ind Pharm; 2012 May; 38(5):571-6. PubMed ID: 21980925
[TBL] [Abstract][Full Text] [Related]
13. Influence of electronic and formulation variables on transdermal iontophoresis of tacrine hydrochloride.
Patel N; Jain S; Madan P; Lin S
Pharm Dev Technol; 2015 Jun; 20(4):442-57. PubMed ID: 24467234
[TBL] [Abstract][Full Text] [Related]
14. Transdermal iontophoretic delivery of tacrine hydrochloride: Correlation between in vitro permeation and in vivo performance in rats.
Patel N; Jain S; Lin S
Int J Pharm; 2016 Nov; 513(1-2):393-403. PubMed ID: 27633278
[TBL] [Abstract][Full Text] [Related]
15. Enhanced iontophoretic delivery of buspirone hydrochloride across human skin using chemical enhancers.
Meidan VM; Al-Khalili M; Michniak BB
Int J Pharm; 2003 Oct; 264(1-2):73-83. PubMed ID: 12972337
[TBL] [Abstract][Full Text] [Related]
16. Transdermal delivery of vancomycin hydrochloride: Influence of chemical and physical permeation enhancers.
Datta D; Panchal DS; Venuganti VVK
Int J Pharm; 2021 Jun; 602():120663. PubMed ID: 33933644
[TBL] [Abstract][Full Text] [Related]
17. Controlled delivery of ropinirole hydrochloride through skin using modulated iontophoresis and microneedles.
Singh ND; Banga AK
J Drug Target; 2013 May; 21(4):354-66. PubMed ID: 23311703
[TBL] [Abstract][Full Text] [Related]
18. Design and Characterization of Atenolol Transdermal Therapeutic Systems: Enhancement of Permeability via Iontophoresis.
Keerthi H; Panakanti PK; Yamsani MR
PDA J Pharm Sci Technol; 2012; 66(4):318-32. PubMed ID: 22767881
[TBL] [Abstract][Full Text] [Related]
19. In vitro transdermal iontophoretic delivery of penbutolol sulfate.
Ita KB; Banga AK
Drug Deliv; 2009 Jan; 16(1):11-4. PubMed ID: 19555303
[TBL] [Abstract][Full Text] [Related]
20. Using transdermal iontophoresis to increase granisetron delivery across skin in vitro and in vivo: effect of experimental conditions and a comparison with other enhancement strategies.
Cázares-Delgadillo J; Ganem-Rondero A; Quintanar-Guerrero D; López-Castellano AC; Merino V; Kalia YN
Eur J Pharm Sci; 2010 Mar; 39(5):387-93. PubMed ID: 20096354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
